{
  "actions": [
    {
      "acted_at": "2022-11-16",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2022-11-16",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2022-11-17",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr9321-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "N000002",
      "district": "10",
      "name": "Nadler, Jerrold",
      "original_cosponsor": true,
      "sponsored_at": "2022-11-16",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000618",
      "district": "45",
      "name": "Porter, Katie",
      "original_cosponsor": true,
      "sponsored_at": "2022-11-16",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-11-16",
  "number": "9321",
  "official_title": "To amend the Public Health Service Act to provide for the development and publication of independent value assessments for drugs, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Independent Drug Value Assessment Act",
  "sponsor": {
    "bioguide_id": "S001175",
    "district": "14",
    "name": "Speier, Jackie",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-11-16",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2022-11-16",
    "date": "2023-08-15T15:39:31Z",
    "text": "Independent Drug Value Assessment Act\n\nThis bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system)."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Independent Drug Value Assessment Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Independent Drug Value Assessment Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Public Health Service Act to provide for the development and publication of independent value assessments for drugs, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-08-15T15:45:20Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr9321.xml"
}